Skip to Main Content

Author Details

AmirAli Talasaz
University of California San Diego Moores Cancer Center
2006
40
28
PMIDPaper TitleJournal TitlePublished Year
33926918Minimal Residual Disease Detection using a Plasma-only Circulating Tumor DNA Assay in Patients with Colorectal Cancer.Clin Cancer Res2021
31538493Lung cancer and a bold new vision.Future Oncol2020
32017048Minimum Technical Data Elements for Liquid Biopsy Data Submitted to Public Databases.Clin Pharmacol Ther2020
32365229Spectrum of driver mutations and clinical impact of circulating tumor DNA analysis in non-small cell lung cancer: Analysis of over 8000 cases.Cancer2020
30279110Targeted Tissue and Cell-Free Tumor DNA Sequencing of Advanced Lung Squamous-Cell Carcinoma Reveals Clinically Significant Prevalence of Actionable Alterations.Clin Lung Cancer2019
31383735Validation of Microsatellite Instability Detection Using a Comprehensive Plasma-Based Genotyping Panel.Clin Cancer Res2019
31315834Tumor Genomic Profiling Guides Patients with Metastatic Gastric Cancer to Targeted Treatment: The VIKTORY Umbrella Trial.Cancer Discov2019
31363003Molecular Profiling of Hepatocellular Carcinoma Using Circulating Cell-Free DNA.Clin Cancer Res2019
31032472Genomic Assessment of Blood-Derived Circulating Tumor DNA in Patients With Colorectal Cancers: Correlation With Tissue Sequencing, Therapeutic Response, and Survival.JCO Precis Oncol2019
30462160Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge.Ann Oncol2019
30620391Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer.Cancer2019
29196463Genomic Landscape of Cell-Free DNA in Patients with Colorectal Cancer.Cancer Discov2018
32913981Multiplex Gene Profiling of Cell-Free DNA in Patients With Metastatic Melanoma for Monitoring Disease.JCO Precis Oncol2018
30013197Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer.Nat Med2018
29776953The Landscape of Actionable Genomic Alterations in Cell-Free Circulating Tumor DNA from 21,807 Advanced Cancer Patients.Clin Cancer Res2018
29691297Validation of a Plasma-Based Comprehensive Cancer Genotyping Assay Utilizing Orthogonal Tissue- and Plasma-Based Methodologies.Clin Cancer Res2018
29409051Impact of genomic alterations on lapatinib treatment outcome and cell-free genomic landscape during HER2 therapy in HER2+ gastric cancer patients.Ann Oncol2018
29487225Next-Generation Sequencing of Circulating Tumor DNA Reveals Frequent Alterations in Advanced Hepatocellular Carcinoma.Oncologist2018
28850629Clinical utility of circulating cell-free DNA in advanced colorectal cancer.PLoS One2017
32913970Prospective Feasibility Study for Using Cell-Free Circulating Tumor DNA-Guided Therapy in Refractory Metastatic Solid Cancers: An Interim Analysis.JCO Precis Oncol2017
28187516Collaborating to Compete: Blood Profiling Atlas in Cancer (BloodPAC) Consortium.Clin Pharmacol Ther2017
28539465Utility of Genomic Assessment of Blood-Derived Circulating Tumor DNA (ctDNA) in Patients with Advanced Lung Adenocarcinoma.Clin Cancer Res2017
28807936Genomic Alterations in Circulating Tumor DNA from Diverse Cancer Patients Identified by Next-Generation Sequencing.Cancer Res2017
26848768Detection rate of actionable mutations in diverse cancers using a biopsy-free (blood) circulating tumor cell DNA assay.Oncotarget2016
26251290A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma.Clin Cancer Res2016
27602770Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer.Oncotarget2016
26109333Cell-Free DNA Next-Generation Sequencing in Pancreatobiliary Carcinomas.Cancer Discov2015
26452027Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients.Oncotarget2015
26474073Analytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNA.PLoS One2015
25331798Transcriptome analysis of CD133-positive stem cells and prognostic value of survivin in colorectal cancer.Cancer Genomics Proteomics2014
22586443Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines.PLoS One2012
23145101mRNA-Seq of single prostate cancer circulating tumor cells reveals recapitulation of gene expression and pathways found in prostate cancer.PLoS One2012
19234122Isolating highly enriched populations of circulating epithelial cells and other rare cells from blood using a magnetic sweeper device.Proc Natl Acad Sci U S A2009
20467571A Microfluidic Platform for Characterization of Protein-Protein Interactions.IEEE Sens J2009
19417910Electrical detection of protein biomarkers using bioactivated microfluidic channels.Lab Chip2009
18078298Conformational flexibility of a model protein upon immobilization on self-assembled monolayers.Biotechnol Bioeng2008
19693402Targeted cell detection based on microchannel gating.Biomicrofluidics2007
17001006Prediction of protein orientation upon immobilization on biological and nonbiological surfaces.Proc Natl Acad Sci U S A2006
17945673Cell trapping in activated micropores for functional analysis.Conf Proc IEEE Eng Med Biol Soc2006
17946483Modeling of the bioactivated nanopore devices.Conf Proc IEEE Eng Med Biol Soc2006
  • 1 - 40 of 40

Recommended Authors

Yu Jen Jan
Cedars-Sinai Medical Center
Career Start Year 2017
Number of shared co-authors 3
Stephanie J Yaung
Roche Sequencing Solutions Inc.
Career Start Year 2011
Number of shared co-authors 0
Stephanie S Yee
University of Pennsylvania
Career Start Year 2010
Number of shared co-authors 1
Eliezer M Van Allen
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 8
Xinmin Li
University of California los angeles
Career Start Year 2008
Number of shared co-authors 0
Samuel S Freeman
St Vincent's Hospital Melbourne
Career Start Year 2006
Number of shared co-authors 4
Arezou A Ghazani
Brigham and Women's Hospital, USA Harvard Medical School
Career Start Year 2006
Number of shared co-authors 1
Wendell D Jones
Department of Bioinformatics and Clinical Systems
Career Start Year 2006
Number of shared co-authors 3
Robert Sebra
Icahn School of Medicine at Mount Sinai
Career Start Year 2004
Number of shared co-authors 2
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 2
Olivier Harismendy
University of California
Career Start Year 2003
Number of shared co-authors 3
Trevor J Pugh
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2003
Number of shared co-authors 0
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 8
Michaela Bowden
Dana-Farber Cancer Institute
Career Start Year 2002
Number of shared co-authors 4
David T Miyamoto
Massachusetts General Hospital
Career Start Year 2000
Number of shared co-authors 1
Joshua M Lang
19University of Wisconsin Carbone Cancer Center.
Career Start Year 2000
Number of shared co-authors 4
Andrea Sboner
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 7
Jie-Fu Chen
Memorial Sloan Kettering Cancer Center
Career Start Year 1999
Number of shared co-authors 3
Kenna R Mills Shaw
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 7
Martijn P Lolkema
Erasmus MC Cancer Institute
Career Start Year 1999
Number of shared co-authors 2
Paul T Spellman
Oregon Health & Science University Hospital.
Career Start Year 1998
Number of shared co-authors 2
Jorge Nieva
Norris Comprehensive Cancer Center, University of Southern California
Career Start Year 1995
Number of shared co-authors 6
Aaron M Newman
Stanford University
Career Start Year 1994
Number of shared co-authors 1
Sudhir Srivastava
National Cancer Institute
Career Start Year 1992
Number of shared co-authors 2
Gregory J Tsongalis
Dartmouth Health and the Dartmouth Cancer Center, USA Geisel School of Medicine
Career Start Year 1990
Number of shared co-authors 0
Nisha Kanwar
University of Toronto, the Hospital for Sick Children.
Career Start Year 1989
Number of shared co-authors 0
Katherine Stemke-Hale
MD Anderson Cancer Center, University of Texas
Career Start Year 1989
Number of shared co-authors 3
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 2
Elaine R Mardis
The Ohio State University
Career Start Year 1988
Number of shared co-authors 5
Francesca Demichelis
University of Trento
Career Start Year 1969
Number of shared co-authors 9

Collaborators

Ronald W Davis
Stanford University
Co-authored papers 9
Mostafa Ronaghi
Co-authored papers 8
Sung Tae Kim
Busan Paik Hospital, Inje University
Co-authored papers 7
Jeeyun Lee
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 6
Joon Oh Park
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 6
Rebecca Nagy
Guardant Health Inc.
Co-authored papers 5
Scott Kopetz
University of Texas MD Anderson Cancer Center
Co-authored papers 5
Kyoung-Mee Kim
Seoul National University College of Medicine
Co-authored papers 4
Peter Kuhn
University of Tubingen
Co-authored papers 3
Eric A Collisson
University of California san francisco
Co-authored papers 3
Sadakatsu Ikeda
Tokyo Medical and Dental University Hospital
Co-authored papers 3
Paul T Fanta
University of California San Diego Moores Cancer Center
Co-authored papers 3
Min Gew Choi
Research Institute, National Cancer Center
Co-authored papers 3
Michael N Mindrinos
Stanford University
Co-authored papers 3
Anand Kolatkar
Michelson Center for Convergent Bioscience, University of Southern California
Co-authored papers 2
Walt Wells
Center for Translational Data Science, University of Chicago
Co-authored papers 2
Dave S B Hoon
Saint John's Cancer Institute at Saint John's Health Center
Co-authored papers 2
Muneesh Tewari
University of Michigan ann arbor
Co-authored papers 2
Hsian-Rong Tseng
Jonsson Comprehensive Cancer Center, University of California los angeles
Co-authored papers 2
James Godsey
Illumina Inc.
Co-authored papers 2
Gideon M Blumenthal
Oncology Center of Excellence
Co-authored papers 2
David A Eberhard
Lineberger Comprehensive Cancer Center, University of North Carolina
Co-authored papers 2
Ryan Dittamore
Decipher Biosciences Inc.
Co-authored papers 2
Kyung Kim
Samsung Medical Center, Sungkyunkwan University School of Medicine
Co-authored papers 2
Allison Welsh
Exact Sciences Corporation
Co-authored papers 2
Arne Gruen
Charite-University Hospital Berlin
Co-authored papers 2
James Hicks
Michelson Center for Convergent Bioscience, University of Southern California
Co-authored papers 2
Robert L Grossman
University of Chicago
Co-authored papers 2
Phillip G Febbo
Illumina Inc.
Co-authored papers 2
Jake Vinson
Prostate Cancer Clinical Trials Consortium (PCCTC)
Co-authored papers 2
Release 1.2